Celldex Therapeutics
CLDX
#4181
Rank
A$4.21 B
Marketcap
A$53.70
Share price
-1.90%
Change (1 day)
43.92%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2026 (TTM): -A$0.47 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are A$0.86 Million. In 2025 the company made an earning of -A$0.41 Billion a decrease over its 2024 earnings that were of -A$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.47 Billion14.14%
2025 -A$0.41 Billion47.31%
2024 -A$0.28 Billion37.34%
2023 -A$0.2 Billion32.63%
2022 -A$0.16 Billion54.88%
2021 -A$97.1 Million39.49%
2020 -A$69.62 Million-9.08%
2019 -A$76.57 Million-28.64%
2018 -A$0.11 Billion-30.11%
2017 -A$0.16 Billion-17.75%
2016 -A$0.19 Billion4.5%
2015 -A$0.18 Billion4.09%
2014 -A$0.18 Billion51.57%
2013 -A$0.12 Billion40.1%
2012 -A$80.81 Million
2010 -A$1.76 Million-96.59%
2009 -A$51.4 Million
2006 -A$31.41 Million
2004 -A$19.08 Million15.75%
2003 -A$16.48 Million-18.69%
2002 -A$20.27 Million-41.22%
2001 -A$34.48 Million59%
2000 -A$21.69 Million27.65%
1999 -A$16.99 Million53.12%
1998 -A$11.1 Million2.6%
1997 -A$10.82 Million-33.62%
1996 -A$16.29 Million-1.69%
1995 -A$16.57 Million22.92%
1994 -A$13.49 Million-0%
1993 -A$13.49 Million
1991 -A$8.29 Million90.32%
1990 -A$4.36 Million10.71%
1989 -A$3.94 Million833.33%
1988 -A$0.43 Million-400%
1987 A$0.14 M-125%
1986 -A$0.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.87 B-3,526.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.75 B-3,040.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.05 B-3,339.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-A$3.94 Million-99.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.12 Billion 155.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.16 B-138.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$82.98 M-119.12%๐Ÿ‡บ๐Ÿ‡ธ USA